BioSpace News Archive

This agreement defines an exclusive option to obtain licences for joint programs including Otoferlin & Usher Type 1 and preference rights on the research pipeline in the field of genetic disorders of the inner ear in order to set up future collaborations

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China’s prescription drug market, announced the “non-PVC solid-liquid double chamber bag for ceftazidime/sodium chloride injection” jointly developed by the Group and its associated company Beijing Ruiye Drugs Manufacture Co.

Medivir AB announces that the company will participate at the Redeye Pre-ASCO Seminar in Stockholm.

Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company in China, described the blueprint of their China’s precision medicine at the Nature conference: Genome Variation in Precision Medicine 2019 held in Nanjing, China, on Sunday.

The global gene therapy for inherited genetic disorders market is expected to post a CAGR of about 189% during the period 2019-2023, according to the latest market research report by Technavio.

Dr. Mark Powzaniuk will join Molekule Consulting as Head of Oncology Practice on May 27, 2019.

CathVision ApS announced the addition of two industry leaders to its Board of Directors.

CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd.

According to the latest market research report by Technavio, the global surgical smoke evacuation systems market is expected to post a CAGR of almost 7% during the period 2019-2023.

Nordic Nanovector ASA announces that members of its senior management team will participate and present at the following upcoming investor conferences during May and June: